Xylonix and Genecast Join Forces to Transform Cancer Metastasis Research
Xylonix, a fast-growing Singapore-based pharmaceutical company specializing in innovative oncology and immunology products, is proud to announce a strategic partnership with Genecast, a pioneering cancer diagnostics company from Korea. This collaboration aims to advance the field of early precision cancer diagnostics and cancer metastasis research, leveraging Genecast’s cutting-edge ADPS-PCR technology. Genecast’s
